GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The IBN SINA Pharmaceutical Industry PLC (DHA:IBNSINA) » Definitions » EV-to-FCF

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) EV-to-FCF : (As of May. 01, 2024)


View and export this data going back to . Start your Free Trial

What is The IBN SINA Pharmaceutical Industry EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, The IBN SINA Pharmaceutical Industry's Enterprise Value is BDT0.00 Mil. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate its Free Cash Flow for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate The IBN SINA Pharmaceutical Industry's EV-to-FCF at this moment.

The historical rank and industry rank for The IBN SINA Pharmaceutical Industry's EV-to-FCF or its related term are showing as below:

DHA:IBNSINA's EV-to-FCF is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.28
* Ranked among companies with meaningful EV-to-FCF only.

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-01), The IBN SINA Pharmaceutical Industry's stock price is BDT255.40. The IBN SINA Pharmaceutical Industry does not have enough years/quarters to calculate its Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in . 20. Therefore, GuruFocus does not calculate The IBN SINA Pharmaceutical Industry's PE Ratio at this moment.


The IBN SINA Pharmaceutical Industry EV-to-FCF Historical Data

The historical data trend for The IBN SINA Pharmaceutical Industry's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The IBN SINA Pharmaceutical Industry EV-to-FCF Chart

The IBN SINA Pharmaceutical Industry Annual Data
Trend
EV-to-FCF

The IBN SINA Pharmaceutical Industry Semi-Annual Data
EV-to-FCF

Competitive Comparison of The IBN SINA Pharmaceutical Industry's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, The IBN SINA Pharmaceutical Industry's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


The IBN SINA Pharmaceutical Industry's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The IBN SINA Pharmaceutical Industry's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where The IBN SINA Pharmaceutical Industry's EV-to-FCF falls into.



The IBN SINA Pharmaceutical Industry EV-to-FCF Calculation

The IBN SINA Pharmaceutical Industry's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=0.000/
=


The IBN SINA Pharmaceutical Industry  (DHA:IBNSINA) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

The IBN SINA Pharmaceutical Industry's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=255.40/
=

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


The IBN SINA Pharmaceutical Industry EV-to-FCF Related Terms

Thank you for viewing the detailed overview of The IBN SINA Pharmaceutical Industry's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Business Description

Traded in Other Exchanges
N/A
Address
Mirpur Road, Tanin Center, 3 Asad Gate, Mohammadpur, Dhaka, BGD, 1207
The IBN SINA Pharmaceutical Industry PLC is engaged in the production and marketing of pharmaceutical drugs and natural medicines in both the local and international market.

The IBN SINA Pharmaceutical Industry (DHA:IBNSINA) Headlines

No Headlines